These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14154337)

  • 61. Limitations of non-ceruloplasmin-bound copper in routine clinical practice.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    Gut; 2007 Jan; 56(1):154. PubMed ID: 17172594
    [No Abstract]   [Full Text] [Related]  

  • 62. Studies of mass infant screening for Wilson disease by urinary ceruloplasmin.
    Kinoshita Y; Yamakami Y; Mori Y; Haruki E; Kikuchi N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():149-50. PubMed ID: 11400755
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 294 MEDICOLEGAL AUTOPSIES ON EPILEPTICS, CEREBRAL FINDINGS.
    FREYTAG E; LINDENBERG R
    Arch Pathol; 1964 Sep; 78():274-86. PubMed ID: 14167379
    [No Abstract]   [Full Text] [Related]  

  • 64. Role of citrate in abnormal copper metabolism.
    Nath R; Srivastava SK
    Metabolism; 1965 Dec; 14(12):1237-9. PubMed ID: 5845495
    [No Abstract]   [Full Text] [Related]  

  • 65. Effect of ceruloplasmin on 6-hydroxydopamine oxidation.
    Medda R; Calabrese L; Musci G; Padiglia A; Floris G
    Biochem Mol Biol Int; 1996 Apr; 38(4):721-8. PubMed ID: 8728101
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 67. Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values.
    Gault MH; Stein J; Aronoff A
    Gastroenterology; 1966 Jan; 50(1):8-18. PubMed ID: 5900960
    [No Abstract]   [Full Text] [Related]  

  • 68. [Wilson's Disease].
    Ramseier SP; Jung HH
    Praxis (Bern 1994); 2010 Feb; 99(3):175-82. PubMed ID: 20127637
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Isolation and physico-chemical properties of rat ceruloplasmin].
    Zakharova ET; Vasil'ev VB; Gorbunova VN; Shavlovskiĭ MM
    Biokhimiia; 1983 Oct; 48(10):1709-20. PubMed ID: 6639990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories.
    Twomey PJ; Viljoen A; Reynolds TM; Wierzbicki AS
    J Trace Elem Med Biol; 2008; 22(1):50-3. PubMed ID: 18319140
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Finding the optimal multiple-test strategy using a method analogous to logistic regression: the diagnosis of hepatolenticular degeneration (Wilson's disease).
    Richards RJ; Hammitt JK; Tsevat J
    Med Decis Making; 1996; 16(4):367-75. PubMed ID: 8912298
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Plasma levels of ceruloplasmin and copper in children with hepatic damage].
    Larrain F; Urbina AM; Lorenzo C; Danus O
    Rev Chil Pediatr; 1975; 46(4):351-5. PubMed ID: 1233556
    [No Abstract]   [Full Text] [Related]  

  • 73. [The value of biochemical determination of copper in clinical diagnosis of hepatolenticular degeneration].
    Li NZ
    Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):342-5. PubMed ID: 6414660
    [No Abstract]   [Full Text] [Related]  

  • 74. The copper connection.
    Linn FH; van Erpecum KJ; Klomp LW; Houwen RH
    Eur J Neurol; 2009 Oct; 16(10):1073-4. PubMed ID: 19566898
    [No Abstract]   [Full Text] [Related]  

  • 75. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease.
    Stuerenburg HJ
    J Neural Transm (Vienna); 2000; 107(3):321-9. PubMed ID: 10821440
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [On the psychiatric-clinical diagnosis of cerebrovascular sclerosis].
    SCHULTE W
    Medizinische; 1959 Dec; No 50():2473-8. PubMed ID: 14443764
    [No Abstract]   [Full Text] [Related]  

  • 77. Ceruloplasmin in Wilson's disease.
    Holtzman NA; Naughton MA; Iber FL; Gaumnitz BM
    J Clin Invest; 1967 Jun; 46(6):993-1002. PubMed ID: 6026104
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The role of cytochrome c in the redox reactions of ceruloplasmin].
    Derkachev EF; Shaposhnikov AM
    Biokhimiia; 1972; 37(1):209-12. PubMed ID: 5017921
    [No Abstract]   [Full Text] [Related]  

  • 79. [BLOOD COPPER AND CERULOPLASMIN IN HODGKIN'S DISEASE].
    THORLING EB; JENSEN KB; ANDERSEN CJ; JENSEN K
    Folia Clin Int (Barc); 1965 Jan; 15():12-26. PubMed ID: 14311723
    [No Abstract]   [Full Text] [Related]  

  • 80. Relationships between the copper atoms of caeruloplasmin. 3. A difference in the reactivity of the chromophoric sites.
    Marriott J; Perkins DJ
    Biochim Biophys Acta; 1968 Apr; 154(3):501-6. PubMed ID: 5650417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.